AIMZ Investment Advisors LLC lowered its stake in shares of CIGNA Co. (NYSE:CI) by 4.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,550 shares of the health services provider’s stock after selling 375 shares during the period. AIMZ Investment Advisors LLC’s holdings in CIGNA were worth $1,736,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors also recently added to or reduced their stakes in CI. Financial Gravity Companies Inc. purchased a new position in shares of CIGNA in the fourth quarter valued at $112,000. Stuart Chaussee & Associates Inc. purchased a new position in shares of CIGNA in the fourth quarter valued at $122,000. Cerebellum GP LLC purchased a new position in shares of CIGNA in the fourth quarter valued at $127,000. Horan Capital Advisors LLC. purchased a new position in shares of CIGNA in the third quarter valued at $123,000. Finally, Aevitas Wealth Management Inc. purchased a new position in shares of CIGNA in the fourth quarter valued at $162,000. Hedge funds and other institutional investors own 88.87% of the company’s stock.
In other news, EVP Nicole S. Jones sold 5,856 shares of CIGNA stock in a transaction on Monday, March 5th. The stock was sold at an average price of $190.68, for a total transaction of $1,116,622.08. Following the completion of the sale, the executive vice president now directly owns 36,658 shares in the company, valued at $6,989,947.44. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director William D. Zollars sold 212 shares of CIGNA stock in a transaction on Wednesday, January 10th. The stock was sold at an average price of $205.68, for a total value of $43,604.16. Following the sale, the director now owns 13,500 shares of the company’s stock, valued at $2,776,680. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 86,103 shares of company stock valued at $17,217,951. Corporate insiders own 1.30% of the company’s stock.
CIGNA Co. (CI) opened at $167.31 on Tuesday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.37 and a current ratio of 0.37. The company has a market cap of $41,250.00, a price-to-earnings ratio of 17.32, a price-to-earnings-growth ratio of 1.04 and a beta of 0.51. CIGNA Co. has a one year low of $143.85 and a one year high of $227.13.
CIGNA (NYSE:CI) last posted its quarterly earnings data on Thursday, February 1st. The health services provider reported $1.94 EPS for the quarter, topping the consensus estimate of $1.87 by $0.07. The company had revenue of $10.53 billion during the quarter, compared to analyst estimates of $10.28 billion. CIGNA had a net margin of 5.38% and a return on equity of 18.84%. CIGNA’s quarterly revenue was up 5.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.87 earnings per share. equities analysts anticipate that CIGNA Co. will post 12.9 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 10th. Stockholders of record on Monday, March 12th will be given a dividend of $0.04 per share. The ex-dividend date is Friday, March 9th. This represents a $0.16 annualized dividend and a dividend yield of 0.10%. CIGNA’s dividend payout ratio (DPR) is 0.41%.
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.